S 3314119th CongressIn Committee
Written Informed Consent Act
Standard Summary
Balanced plain-English summary
The Written Informed Consent Act directs the Secretary of Veterans Affairs to expand Veterans Health Administration Directive 1005, which currently addresses informed consent for long-term opioid therapy for pain, so that it also applies to antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics.
Key Points
- 1Requires the VA Secretary to update VHA Directive 1005 on informed consent.
- 2Extends the directive beyond long-term opioid therapy to additional medication classes.
- 3Covered medications include antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics.
- 4Aims to strengthen written informed consent requirements for veterans receiving certain medications.
Impact Areas
Veterans receiving VA healthcareVA clinicians and prescribersVA pharmacies and health systemsVeterans Health Administration policy operations
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026